Literature DB >> 22677549

Knocking out podocyte rho GTPases: and the winner is...

Mark A Lal, Karl Tryggvason.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22677549     DOI： 10.1681/ASN.2012050494

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  3 in total

1.  Adrenomedullin ameliorates podocyte injury induced by puromycin aminonucleoside in vitro and in vivo through modulation of Rho GTPases.

Authors:  Nan Dong; Lixia Meng; Ruqun Xue; Meng Yu; Zhonghua Zhao; Xueguang Liu
Journal:  Int Urol Nephrol       Date:  2017-05-20       Impact factor: 2.370

2.  ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling.

Authors:  Heon Yung Gee; Pawaree Saisawat; Shazia Ashraf; Toby W Hurd; Virginia Vega-Warner; Humphrey Fang; Bodo B Beck; Olivier Gribouval; Weibin Zhou; Katrina A Diaz; Sivakumar Natarajan; Roger C Wiggins; Svjetlana Lovric; Gil Chernin; Dominik S Schoeb; Bugsu Ovunc; Yaacov Frishberg; Neveen A Soliman; Hanan M Fathy; Heike Goebel; Julia Hoefele; Lutz T Weber; Jeffrey W Innis; Christian Faul; Zhe Han; Joseph Washburn; Corinne Antignac; Shawn Levy; Edgar A Otto; Friedhelm Hildebrandt
Journal:  J Clin Invest       Date:  2013-07-08       Impact factor: 14.808

3.  Rhophilin-1 is a key regulator of the podocyte cytoskeleton and is essential for glomerular filtration.

Authors:  Mark A Lal; Ann-Charlotte Andersson; Kan Katayama; Ziejie Xiao; Masatoshi Nukui; Kjell Hultenby; Annika Wernerson; Karl Tryggvason
Journal:  J Am Soc Nephrol       Date:  2014-07-28       Impact factor: 10.121
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.